Literature DB >> 15338054

Role of nitric oxide in the functional response to ischemia-reperfusion of heart mitochondria from hyperthyroid rats.

P Venditti1, R De Rosa, L Cigliano, C Agnisola, S Di Meo.   

Abstract

We investigated the role of nitric oxide (NO) in the mitochondrial derangement associated with the functional response to ischemia-reperfusion of hyperthyroid rat hearts. Mitochondria were isolated at 3000 g from hearts subjected to ischemia-reperfusion, with or without N(omega)-nitro-L-arginine (L-NNA, an NO synthase inhibitor). During reperfusion, hyperthyroid hearts displayed tachycardia and low functional recovery. Their mitochondria exhibited O(2) consumption similar to euthyroid controls, while H(2)O(2) production, hydroperoxide, protein-bound carbonyl and nitrotyrosine levels, and susceptibility to swelling were higher. L-NNA blocked the reperfusion tachycardic response and increased inotropic recovery in hyperthyroid hearts. L-NNA decreased mitochondrial H(2)O(2) production and oxidative damage, and increased respiration and tolerance to swelling. Such effects were higher in hyperthyroid preparations. These results confirm the role of mitochondria in ischemia-reperfusion damage, and strongly suggest that NO overproduction is involved in the high mitochondrial dysfunction and the low recovery of hyperthyroid hearts from ischemia-reperfusion. L-NNA also decreased protein content and cytochrome oxidase activity of a mitochondrial fraction isolated at 8000 g. This and previous results suggest that the above fraction contains, together with light mitochondria, damaged mitochondria coming from the heaviest fraction, which has the highest cytochrome oxidase activity and capacity to produce H(2)O(2). Therefore, we propose that the high mitochondrial susceptibility to swelling, favoring mitochondrial population purification from H(2)O(2)-overproducing mitochondria, limits hyperthyroid heart oxidative stress.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15338054     DOI: 10.1007/s00018-004-4125-9

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  24 in total

1.  Mortality and prehospital thrombolysis for acute myocardial infarction: A meta-analysis.

Authors:  L J Morrison; P R Verbeek; A C McDonald; B V Sawadsky; D J Cook
Journal:  JAMA       Date:  2000 May 24-31       Impact factor: 56.272

2.  Impact of time to treatment on mortality after prehospital fibrinolysis or primary angioplasty: data from the CAPTIM randomized clinical trial.

Authors:  Philippe Gabriel Steg; Eric Bonnefoy; Sylvie Chabaud; Frédéric Lapostolle; Pierre-Yves Dubien; Pascal Cristofini; Alain Leizorovicz; Paul Touboul
Journal:  Circulation       Date:  2003-11-17       Impact factor: 29.690

3.  Benefit of transferring ST-segment-elevation myocardial infarction patients for percutaneous coronary intervention compared with administration of onsite fibrinolytic declines as delays increase.

Authors:  Duane S Pinto; Paul D Frederick; Anjan K Chakrabarti; Ajay J Kirtane; Edward Ullman; Andre Dejam; Dave P Miller; Timothy D Henry; C Michael Gibson
Journal:  Circulation       Date:  2011-11-07       Impact factor: 29.690

4.  Timely PCI for STEMI--still the treatment of choice.

Authors:  Deepak L Bhatt
Journal:  N Engl J Med       Date:  2013-03-10       Impact factor: 91.245

5.  Prehospital thrombolytic therapy in patients with suspected acute myocardial infarction.

Authors: 
Journal:  N Engl J Med       Date:  1993-08-05       Impact factor: 91.245

6.  Impact of community intervention to reduce patient delay time on use of reperfusion therapy for acute myocardial infarction: rapid early action for coronary treatment (REACT) trial. REACT Study Group.

Authors:  J R Hedges; H A Feldman; V Bittner; R J Goldberg; J Zapka; S K Osganian; D M Murray; D G Simons-Morton; A Linares; J Williams; R V Luepker; M S Eisenberg
Journal:  Acad Emerg Med       Date:  2000-08       Impact factor: 3.451

7.  Reduction of treatment delay in patients with ST-elevation myocardial infarction: impact of pre-hospital diagnosis and direct referral to primary percutanous coronary intervention.

Authors:  Christian Juhl Terkelsen; Jens Flensted Lassen; Bjarne Linde Nørgaard; Jens Christian Gerdes; Steen Hvitfeldt Poulsen; Kristoffer Bendix; Jens Peter Ankersen; Liv Bjørn-Hansen Gøtzsche; Frode Kirketerp Rømer; Torsten Toftegaard Nielsen; Henning Rud Andersen
Journal:  Eur Heart J       Date:  2005-01-31       Impact factor: 29.983

8.  An evaluation of the results of media and educational campaigns designed to shorten the time taken by patients with acute myocardial infarction to decide to go to hospital.

Authors:  M B Blohm; M Hartford; B W Karlson; R V Luepker; J Herlitz
Journal:  Heart       Date:  1996-11       Impact factor: 5.994

9.  System delay and mortality among patients with STEMI treated with primary percutaneous coronary intervention.

Authors:  Christian Juhl Terkelsen; Jacob Thorsted Sørensen; Michael Maeng; Lisette Okkels Jensen; Hans-Henrik Tilsted; Sven Trautner; Werner Vach; Søren Paaske Johnsen; Leif Thuesen; Jens Flensted Lassen
Journal:  JAMA       Date:  2010-08-18       Impact factor: 56.272

10.  2012 ESC STEMI guidelines and reperfusion therapy: Evidence base ignored, threatening optimal patient management.

Authors:  Christian Juhl Terkelsen; Duane S Pinto; Holger Thiele; Peter Clemmensen; Kjell Nikus; Jens Flensted Lassen; David Hildick-Smith; Evald Høj Christiansen; Jens Aarøe; Hans-Henrik Tilsted Hansen; Goran Stankovic; Anders Junker; Georgios Sianos; Göran Olivecrona; Hans Erik Bøtker; Charles Michael Gibson; Eric Boersma
Journal:  Heart       Date:  2013-06-17       Impact factor: 5.994

View more
  8 in total

1.  Acute hypoxia/reoxygenation affects muscle mitochondrial respiration and redox state as well as swimming endurance in zebrafish.

Authors:  G Napolitano; Paola Venditti; G Fasciolo; D Esposito; E Uliano; C Agnisola
Journal:  J Comp Physiol B       Date:  2018-12-17       Impact factor: 2.200

Review 2.  Role of ROS and RNS Sources in Physiological and Pathological Conditions.

Authors:  Sergio Di Meo; Tanea T Reed; Paola Venditti; Victor Manuel Victor
Journal:  Oxid Med Cell Longev       Date:  2016-07-12       Impact factor: 6.543

Review 3.  Vitamin E management of oxidative damage-linked dysfunctions of hyperthyroid tissues.

Authors:  Paola Venditti; Lisa Di Stefano; Sergio Di Meo
Journal:  Cell Mol Life Sci       Date:  2012-12-20       Impact factor: 9.261

4.  Effect of T3 treatment on the response to ischemia-reperfusion of heart preparations from sedentary and trained rats.

Authors:  Paola Venditti; Angela Bari; Lisa Di Stefano; Claudio Agnisola; Sergio Di Meo
Journal:  Pflugers Arch       Date:  2007-08-16       Impact factor: 3.657

Review 5.  Role of Oxidative Stress in Thyroid Hormone-Induced Cardiomyocyte Hypertrophy and Associated Cardiac Dysfunction: An Undisclosed Story.

Authors:  Mohammad T Elnakish; Amany A E Ahmed; Peter J Mohler; Paul M L Janssen
Journal:  Oxid Med Cell Longev       Date:  2015-06-04       Impact factor: 6.543

6.  The effects of ischemic postconditioning on myocardial function and nitric oxide metabolites following ischemia-reperfusion in hyperthyroid rats.

Authors:  Jalal Zaman; Sajjad Jeddi; Asghar Ghasemi
Journal:  Korean J Physiol Pharmacol       Date:  2014-12-30       Impact factor: 2.016

7.  Emerging roles of cardiolipin remodeling in mitochondrial dysfunction associated with diabetes, obesity, and cardiovascular diseases.

Authors:  Yuguang Shi
Journal:  J Biomed Res       Date:  2010-01

8.  Dose-Dependent Effects of Long-Term Administration of Hydrogen Sulfide on Myocardial Ischemia-Reperfusion Injury in Male Wistar Rats: Modulation of RKIP, NF-κB, and Oxidative Stress.

Authors:  Sajad Jeddi; Sevda Gheibi; Khosrow Kashfi; Mattias Carlström; Asghar Ghasemi
Journal:  Int J Mol Sci       Date:  2020-02-19       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.